Price Alert

Estrella Immunopharma Inc... (ESLA)

NASDAQ: ESLA · Real-Time Price · USD

0.90

0.04 (4.60%)

At close: Aug 15, 2025, 2:50 PM

Estrella Immunopharma Cash Flow Statement

Financials in USD. Fiscal year is July - June.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2024	Dec 31, 2022	Jun 30, 2022
Net Income	-7.31M	-996.1K	-1.69M
Depreciation & Amortization	n/a	n/a	n/a
Stock-Based Compensation	1.19M	n/a	129.97K
Other Working Capital	-618.09K	576.86K	113.35K
Other Non-Cash Items	n/a	-654.07K	-1.43K
Deferred Income Tax	n/a	29.47K	n/a
Change in Working Capital	-9.95M	576.86K	113.35K
Operating Cash Flow	-16.07M	-1.04M	-1.44M
Capital Expenditures	-4	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	-45.19M
Sales Maturities Of Investments	n/a	36.17M	n/a
Other Investing Acitivies	4.96M	n/a	n/a
Investing Cash Flow	4.96M	36.17M	-45.19M
Debt Repayment	n/a	498.6K	n/a
Common Stock Repurchased	-354.44K	-36.11M	-25K
Dividend Paid	n/a	n/a	n/a
Other Financial Acitivies	4.13M	50K	530.36K
Financial Cash Flow	12.79M	-35.56M	5.53M
Net Cash Flow	1.69M	-438.07K	4.09M
Free Cash Flow	-16.07M	-1.04M	-1.44M